RUNX1 and acute lymphoblastic leukemia: Stams, et.al., showed that in ALL patients with TEL/AML1 fusion, despite that fact that a consistent increase in ASNS mRNA following L-asparaginase treatment was observed, no correlation was found in overall therapeutic responses [57].